Navigation Links
Bortezomib for salvage therapy against progressive myeloma

Despite the initial efficacy of these therapies against multiple myeloma (MM), relapse is invariably the rule. Bortezomib (Velcade, formerly PS-341, Millennium, USA) is a novel first-class agent that inhibits the proteasome, a // multicatalytic cellular enzyme whose activity entails several molecular mechanisms, including, in particular, the NF-kB pathway.

Currently, bortezomib, alone or in combination with dexamethasone and doxorubicin, is under investigation as first-line and maintenance therapy. However, previous studies on advanced disease included a mixture of patients with multiple and heterogeneous previous regimens. Therefore, in order to obtain more careful information about the efficacy and tolerability of this drug in more homogeneously and less heavily pre-treated patients, researchers from Italy focused on the effects of bortezomib on a selected cohort of MM patients who had progressive disease after previous treatments including exclusively AuSCT and thalidomide. They focused on the effects of bortezomib as third line treatment (second salvage therapy) in a very homogeneous group of MM patients induced by AuSCT and relapsed or refractory after thalidomide employed as second line treatment (first salvage therapy).

For the study to be published in the journal Leukemia Research (available online 18 August 2005), twenty-one patients with multiple myeloma, all relapsed after frontline autologous stem cell transplantation and all relapsed again after or resistant to thalidomide (employed as second line treatment) received bortezomib without adjunct of steroids as third line therapy. Three patients died of progressive disease during the first 2 cycles with bortezomib. Eighteen patients received at least 2 cycles and were evaluated for response. According to EBMT criteria, 2 complete (negative immunofixation) and 7 partial remissions were achieved. Duration of response lasted from 2 to 14+ months. Grades 3?4 toxicities (thrombocytopeni
'"/>




Page: 1 2

Related medicine news :

1. Acupuncture May Help Chemotherapy Side Effects
2. Antioxidants protect health tissue in people undergoing radiation therapy.
3. Distraction therapy found very effective in postoperative patients
4. Acupuncture superseeds massage therapy for short term relief of pain
5. Ovarian cancer in relationship with Hormone therapy
6. New therapy better at increasing bone density
7. Gene therapy - Aim to improve blood flow
8. Gene therapy restores sight
9. Heat therapy relieves back pain
10. Radiotherapy helps in colon cancer
11. New therapy for pimples
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Bortezomib for salvage therapy against progressive myeloma

(Date:11/24/2014)... Abington, PA (PRWEB) November 24, 2014 ... Nataliya Ternopolska, MD has joined The Neurology ... Abington Health’s Multiple Sclerosis Center. , A graduate ... residency in Neurology at Albert Einstein Medical Center in ... the Judith Jaffe Multiple Sclerosis Center at Weill Cornell ...
(Date:11/24/2014)... 2014 A new sports massage ... pain-relief service and massage therapy provider, announced it ... This newest sports massage is a ... between traditional sports massage and ESM is that ... very own "reset button,” and ESM can increase ...
(Date:11/24/2014)... SweetDressy.com, a well-known dress supplier and leader in the ... Dresses. All these fresh items are offered at affordable ... special offer is valid until Dec. 20, 2014. Click ... working well in the fashion industry for years. They ... dresses may be the best products for many ladies ...
(Date:11/24/2014)... (PRWEB) November 24, 2014 SWAccessControl.com ... locks. As a matter of fact, the company is a ... its brand new magnetic locks are available at discounted prices, ... our new range of magnetic locks. This time, all of ... are popular at home and abroad, so I have confidence ...
(Date:11/24/2014)... 2014 The typical American diet includes ... ingredients. Consistently consuming a diet high in calories and ... excess fat that typically accumulate around the internal organs ... ugly head in the form of love handles, beer ... the decision to rid themselves of the burden of ...
Breaking Medicine News(10 mins):Health News:Nataliya Ternopolska Named Associate Medical Director of Abington Health’s Multiple Sclerosis Center 2Health News:Sports Massage in London by Massaggi Presents New Technique to Reset Muscles, Rapidly Eliminate Pain 2Health News:Sports Massage in London by Massaggi Presents New Technique to Reset Muscles, Rapidly Eliminate Pain 3Health News:SweetDressy.com Unveiled A New Selection Of Evening Dresses 2Health News:SWAccessControl.com Is Happy To Release New Range Of Magnetic Locks 2Health News:Ketogenic Diet is the Perfect Solution for Diet Doc Patients Who Want to Learn How to Lose Weight over the Holidays 2Health News:Ketogenic Diet is the Perfect Solution for Diet Doc Patients Who Want to Learn How to Lose Weight over the Holidays 3Health News:Ketogenic Diet is the Perfect Solution for Diet Doc Patients Who Want to Learn How to Lose Weight over the Holidays 4
... THOR ), a world leader in device-based ... failing hearts, said today that it will be participating ... Monday, May 18.David. V. Smith, executive vice president and ... company, beginning at 2 p.m., Pacific Daylight Time, (5 ...
... Highlighted Today at American Society of Clinical Oncology ... Colon Cancer Test in Early 2010-REDWOOD CITY, Calif., ... GHDX ) today announced positive results from ... the Onco type DX(R) colon ...
... ,Help is Here Express, bus tour will be stopping in ... cities in order to help uninsured and financially-struggling Utahans access ... nearly free. With the state,s unemployment rate now hitting 5.2 ... Partnership for Prescription Assistance (PPA) bus tour is raising awareness ...
... (Cayman) Inc.,(NYSE: WX ), a leading research ... device industries, with operations,in China and the United States, ... (Logo: http://www.newscom.com/cgi-bin/prnh/20040705/CNM002LOGO ), ... Revenues Increase 5% Year Over Year to, ...
... storage system extends PreXion3D image scans to network ... ( www.Prexion.com ), a leader in ... availability of DataServer/PX, a DICOM-conformant, massive storage system ... that has accumulated over time through the use ...
... N.J. , May 14 Pharmasset, Inc. (Nasdaq: ... the Deutsche Bank 34th Annual Healthcare Conference. The conference ... MA (May 18 to 19).Schaefer Price, Pharmasset,s President and ... Company at the conference on Monday, May 18, 2009 ...
Cached Medicine News:Health News:Genomic Health's Oncotype DX(R) Colon Cancer Test Predicts Individualized Recurrence Risk for Stage II Colon Cancer Patients 2Health News:Genomic Health's Oncotype DX(R) Colon Cancer Test Predicts Individualized Recurrence Risk for Stage II Colon Cancer Patients 3Health News:Genomic Health's Oncotype DX(R) Colon Cancer Test Predicts Individualized Recurrence Risk for Stage II Colon Cancer Patients 4Health News:Genomic Health's Oncotype DX(R) Colon Cancer Test Predicts Individualized Recurrence Risk for Stage II Colon Cancer Patients 5Health News:Genomic Health's Oncotype DX(R) Colon Cancer Test Predicts Individualized Recurrence Risk for Stage II Colon Cancer Patients 6Health News:Partnership for Prescription Assistance Prepared to Help Utah Workers Hurt by Recession 2Health News:Partnership for Prescription Assistance Prepared to Help Utah Workers Hurt by Recession 3Health News:Partnership for Prescription Assistance Prepared to Help Utah Workers Hurt by Recession 4Health News:WuXi PharmaTech Announces First-Quarter 2009 Results 2Health News:WuXi PharmaTech Announces First-Quarter 2009 Results 3Health News:WuXi PharmaTech Announces First-Quarter 2009 Results 4Health News:WuXi PharmaTech Announces First-Quarter 2009 Results 5Health News:WuXi PharmaTech Announces First-Quarter 2009 Results 6Health News:WuXi PharmaTech Announces First-Quarter 2009 Results 7Health News:WuXi PharmaTech Announces First-Quarter 2009 Results 8Health News:WuXi PharmaTech Announces First-Quarter 2009 Results 9Health News:WuXi PharmaTech Announces First-Quarter 2009 Results 10Health News:WuXi PharmaTech Announces First-Quarter 2009 Results 11Health News:WuXi PharmaTech Announces First-Quarter 2009 Results 12Health News:WuXi PharmaTech Announces First-Quarter 2009 Results 13Health News:WuXi PharmaTech Announces First-Quarter 2009 Results 14Health News:WuXi PharmaTech Announces First-Quarter 2009 Results 15Health News:PreXion Adds a Fast, High-Volume Data Storage and Archiving System for Use With Its PreXion3D CBCT X-ray System 2Health News:Pharmasset to Present at Deutsche Bank Healthcare Conference 2Health News:Pharmasset to Present at Deutsche Bank Healthcare Conference 3
(Date:11/22/2014)... , Nov. 21, 2014  Particle Sciences, Inc ... has developed and manufactured a new innovative vaginal ... Research and Development arm of Exeltis Pharmaceuticals.  According ... Project Management at Particle Sciences, "This vaginal ring ... our material sciences and modeling expertise.  We are ...
(Date:11/21/2014)... , Nov. 21, 2014  Alere Inc. (NYSE: ... diagnostic tests, has appointed Juliet Cunningham as ... Cunningham will be responsible for driving communications with the ... on a series of changes to increase shareholder value, ... to investors," said Namal Nawana, Chief Executive Officer. "We ...
(Date:11/21/2014)... 21, 2014  Tandem Diabetes Care ® , ... device company and manufacturer of the t:slim ® ... Tidepool, a non-profit dedicated to improving diabetes therapy ... that increases diabetes data accessibility. This partnership will ... currently under development, to download and access data ...
Breaking Medicine Technology:Particle Sciences' Clinical Trial Supplies Group Manufactures Innovative Vaginal Ring 2Alere Appoints Juliet Cunningham to Lead Investor Relations 2Tandem Diabetes Care Announces Partnership with Tidepool to Further Expand Access to Diabetes Device Data 2Tandem Diabetes Care Announces Partnership with Tidepool to Further Expand Access to Diabetes Device Data 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: